DK461385A - Stabiliserede injicerbare oploesninger af piroxicam - Google Patents

Stabiliserede injicerbare oploesninger af piroxicam Download PDF

Info

Publication number
DK461385A
DK461385A DK461385A DK461385A DK461385A DK 461385 A DK461385 A DK 461385A DK 461385 A DK461385 A DK 461385A DK 461385 A DK461385 A DK 461385A DK 461385 A DK461385 A DK 461385A
Authority
DK
Denmark
Prior art keywords
piroxicam
solutions
injectable solutions
stabilized injectable
stabilized
Prior art date
Application number
DK461385A
Other languages
English (en)
Other versions
DK165901B (da
DK461385D0 (da
DK165901C (da
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of DK461385D0 publication Critical patent/DK461385D0/da
Publication of DK461385A publication Critical patent/DK461385A/da
Publication of DK165901B publication Critical patent/DK165901B/da
Application granted granted Critical
Publication of DK165901C publication Critical patent/DK165901C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Finger-Pressure Massage (AREA)
DK461385A 1984-10-10 1985-10-09 Stabiliserede injektionsoploesninger af piroxicam DK165901C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3437232 1984-10-10
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam

Publications (4)

Publication Number Publication Date
DK461385D0 DK461385D0 (da) 1985-10-09
DK461385A true DK461385A (da) 1986-04-11
DK165901B DK165901B (da) 1993-02-08
DK165901C DK165901C (da) 1993-06-28

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK461385A DK165901C (da) 1984-10-10 1985-10-09 Stabiliserede injektionsoploesninger af piroxicam

Country Status (22)

Country Link
US (1) US4628053A (da)
EP (1) EP0177870B1 (da)
JP (1) JPS6191116A (da)
KR (1) KR890001001B1 (da)
CN (1) CN85107838B (da)
AT (1) ATE62416T1 (da)
AU (1) AU557184B2 (da)
CA (1) CA1251734A (da)
DD (1) DD238329A5 (da)
DE (2) DE3437232A1 (da)
DK (1) DK165901C (da)
FI (1) FI84315C (da)
GR (1) GR852439B (da)
HU (1) HU195111B (da)
IE (1) IE58267B1 (da)
IL (1) IL76624A0 (da)
NO (1) NO166687C (da)
NZ (1) NZ213758A (da)
PH (1) PH23058A (da)
PT (1) PT81264B (da)
SU (1) SU1482509A3 (da)
ZA (1) ZA857783B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
KR20080059269A (ko) * 2005-09-30 2008-06-26 베링거잉겔하임베트메디카게엠베하 멜록시캄을 함유하는 약제학적 제제
BRPI0617477A2 (pt) * 2005-10-19 2011-07-26 Teva Pharma mistura de partÍculas cristalinas de laquinimod sàdica, composiÇço, processo de cristalizaÇço de laquinimod sàdica, laquinimod sàdica, e, processo para produzir uma composiÇço farmacÊutica
EP2035001B1 (en) * 2006-06-12 2011-11-09 Teva Pharmaceutical Industries Limited Stable laquinimod preparations
PL2682120T3 (pl) * 2007-12-20 2017-02-28 Teva Pharmaceutical Industries, Ltd. Stabilne preparaty lakwinimodu
BRPI0913518A2 (pt) * 2008-09-03 2016-07-26 Teva Pharma composto, composição farmacêutica, e, método de tratamento de um distúrbio mediado por função imune
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
ME02414B (me) * 2009-07-30 2016-09-20 Teva Pharma Tretman kronove bolesti lakvinimodom
EP3064206B1 (en) * 2009-08-10 2019-03-20 Active Biotech AB Treatment of huntington's disease using laquinimod
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US8889627B2 (en) 2011-10-12 2014-11-18 Teva Pharmaceutical Industries, Ltd. Treatment of multiple sclerosis with combination of laquinimod and fingolimod
CN104093310A (zh) 2012-02-03 2014-10-08 泰华制药工业有限公司 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
BR112015010193A2 (pt) 2012-11-07 2017-07-11 Teva Pharma sais de amina de laquinimod
KR20150143499A (ko) 2013-03-14 2015-12-23 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드 나트륨의 결정 및 이의 개선된 제조방법
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
AU2018313933B2 (en) * 2017-08-09 2024-03-07 Dechra Veterinary Products, Llc Therapeutic formulations and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (da) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
PT81264B (pt) 1988-02-17
FI853926A0 (fi) 1985-10-09
NO854011L (no) 1986-04-11
GR852439B (da) 1986-02-10
DK165901B (da) 1993-02-08
NZ213758A (en) 1988-07-28
EP0177870A2 (de) 1986-04-16
EP0177870A3 (en) 1987-06-03
NO166687C (no) 1991-09-04
KR860003013A (ko) 1986-05-19
IE852483L (en) 1986-04-10
IE58267B1 (en) 1993-08-25
PH23058A (en) 1989-03-27
DK461385D0 (da) 1985-10-09
US4628053A (en) 1986-12-09
AU4842185A (en) 1986-04-17
ZA857783B (en) 1987-05-27
PT81264A (en) 1985-11-01
SU1482509A3 (ru) 1989-05-23
JPH03849B2 (da) 1991-01-09
FI853926L (fi) 1986-04-11
DK165901C (da) 1993-06-28
EP0177870B1 (de) 1991-04-10
CA1251734A (en) 1989-03-28
JPS6191116A (ja) 1986-05-09
HUT38541A (en) 1986-06-30
AU557184B2 (en) 1986-12-11
FI84315B (fi) 1991-08-15
DE3437232A1 (de) 1986-04-17
NO166687B (no) 1991-05-21
KR890001001B1 (ko) 1989-04-18
CN85107838B (zh) 1988-08-24
CN85107838A (zh) 1986-07-09
IL76624A0 (en) 1986-02-28
FI84315C (fi) 1991-11-25
DD238329A5 (de) 1986-08-20
DE3582468D1 (de) 1991-05-16
HU195111B (en) 1988-04-28
ATE62416T1 (de) 1991-04-15

Similar Documents

Publication Publication Date Title
DK461385A (da) Stabiliserede injicerbare oploesninger af piroxicam
SE8402560L (sv) Farmaceutisk komposition
IT1200589B (it) Derivati naturali attivita farmagologica
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
IT8119321A0 (it) Procedimento per ottenere eparine di basso peso molecolare dotate di proprieta' farmacologiche elevate, e prodotto cosi' ottenuto.
IT8721213A0 (it) Idroformilazione con l'uso di leganti costituiti da fosfina organico solubile di bassa volatilita'.
FI863652A (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
ES8500738A1 (es) Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
FI944823A (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
IT8047580A0 (it) Derivati di 1,2-diidro-2-osso-4-fe nil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
IT8424283A0 (it) Uso di derivati del tiofene nel trattamento dei tumori, composizioni farmaceutiche che licontengono e composti atti allo scopo.
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
SE8600658D0 (sv) Novel composition of matter
EP0191724A3 (de) 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
IT8121654A0 (it) Derivati tiazolidinici ad attivita' farmacologica, procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK320485A (da) Ether-oxid-derivater af cyclopropylphenoler, deres fremstilling oganvendelse
DK0957892T3 (da) Celluloseether-holdigt hårspray med et lavt indhold af flygtige organiske forbindelser
IT7949113A0 (it) Perfezionamento nelle composizioni farmaceutiche tranquillanti a basedi derivati benzodiazepinici
ATE82861T1 (de) Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien.
GB985773A (en) Improvements in or relating to coated medicinals
DE164635T1 (de) Imidazothiazolmethylenacetohydrazid-derivate, ihre herstellung und pharmazeutische zusammensetzungen mit diuretischer wirkung.

Legal Events

Date Code Title Description
PBP Patent lapsed